TSCAN CUTS 75% OF ITS WORKFORCE

🚨 TScan is cutting 75% of its workforce.

That is three out of every four jobs at the biotech, gone in a single restructuring.

Fierce Biotech reports the cut is being made to clear room for the company's solid tumor programs. Not a wind-down. A reallocation.

Biotechs run on runway. Payroll is the largest recurring line item most of them carry, and when a company decides one program deserves the money, headcount is what pays for it. A 75% reduction is the deepest version of that trade. It signals a company narrowing to a single bet rather than trimming around the edges.

For staff, it is immediate. For investors, it is a statement about where management thinks the value sits and what it is willing to abandon to get there.

No further detail beyond what Fierce Biotech has reported is available at this stage.

Would you hold a biotech that just cut three quarters of its people to chase one program?

#TScan #Biotech #Layoffs #Pharma #causeanuproar